These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1122 related items for PubMed ID: 26194065

  • 1. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y, Cui Y, Wang XL, Shang X, Qi ZG, Xue J, Zhao X, Deng M, Xie ML.
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [Abstract] [Full Text] [Related]

  • 2. Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats.
    Zhao X, Xue J, Wang XL, Zhang Y, Deng M, Xie ML.
    Int Immunopharmacol; 2014 Sep; 22(1):176-81. PubMed ID: 24993341
    [Abstract] [Full Text] [Related]

  • 3. PPARα/γ antagonists reverse the ameliorative effects of osthole on hepatic lipid metabolism and inflammatory response in steatohepatitic rats.
    Zhao X, Wang F, Zhou R, Zhu Z, Xie M.
    Inflammopharmacology; 2018 Apr; 26(2):425-433. PubMed ID: 28236037
    [Abstract] [Full Text] [Related]

  • 4. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
    Abd El-Haleim EA, Bahgat AK, Saleh S.
    Eur J Pharmacol; 2016 Feb 15; 773():59-70. PubMed ID: 26825546
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.
    J Gastroenterol Hepatol; 2012 Feb 15; 27(2):341-50. PubMed ID: 21929649
    [Abstract] [Full Text] [Related]

  • 6. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
    Zhao JS, Zhu FS, Liu S, Yang CQ, Chen XM.
    Chin Med J (Engl); 2012 Jul 15; 125(13):2316-21. PubMed ID: 22882855
    [Abstract] [Full Text] [Related]

  • 7. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
    Jiang Y, Chen L, Wang H, Narisi B, Chen B.
    J Ethnopharmacol; 2015 Dec 24; 176():499-507. PubMed ID: 26571089
    [Abstract] [Full Text] [Related]

  • 8. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.
    Food Chem Toxicol; 2014 Feb 24; 64():94-103. PubMed ID: 24275089
    [Abstract] [Full Text] [Related]

  • 9. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R, Yu Y, Hu S, Zhang J, Yang H, Han B, Cheng Y, Luo X.
    Nutr Res; 2016 Sep 24; 36(9):1022-1030. PubMed ID: 27632923
    [Abstract] [Full Text] [Related]

  • 10. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
    Gao H, Zeng Z, Zhang H, Zhou X, Guan L, Deng W, Xu L.
    Biol Pharm Bull; 2015 Sep 24; 38(5):694-702. PubMed ID: 25947915
    [Abstract] [Full Text] [Related]

  • 11. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
    Suolang PC, Liu BQ, Chen J, De J, Nima ZB, Dunzhu CR.
    J Ethnopharmacol; 2019 May 23; 236():316-325. PubMed ID: 30851372
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.
    Massaro M, Scoditti E, Pellegrino M, Carluccio MA, Calabriso N, Wabitsch M, Storelli C, Wright M, De Caterina R.
    Pharmacol Res; 2016 May 23; 107():125-136. PubMed ID: 26976796
    [Abstract] [Full Text] [Related]

  • 13. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
    Rogue A, Anthérieu S, Vluggens A, Umbdenstock T, Claude N, de la Moureyre-Spire C, Weaver RJ, Guillouzo A.
    Toxicol Appl Pharmacol; 2014 Apr 01; 276(1):73-81. PubMed ID: 24534255
    [Abstract] [Full Text] [Related]

  • 14. Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis.
    Akbari R, Behdarvand T, Afarin R, Yaghooti H, Jalali MT, Mohammadtaghvaei N.
    BMC Pharmacol Toxicol; 2021 Oct 01; 22(1):53. PubMed ID: 34593018
    [Abstract] [Full Text] [Related]

  • 15. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
    Ren T, Zhu J, Zhu L, Cheng M.
    Nutrients; 2017 Feb 27; 9(3):. PubMed ID: 28264426
    [Abstract] [Full Text] [Related]

  • 16. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
    Yoon S, Kim J, Lee H, Lee H, Lim J, Yang H, Shin SS, Yoon M.
    J Ethnopharmacol; 2017 Jan 04; 195():204-213. PubMed ID: 27845265
    [Abstract] [Full Text] [Related]

  • 17. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN, Tao RY, Tian JY, Liu GT, Ye F.
    Life Sci; 2008 May 07; 82(19-20):983-90. PubMed ID: 18417155
    [Abstract] [Full Text] [Related]

  • 18. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX, Yu R, Xu MX, Li PQ, Fan CY, Li JM, Kong LD.
    Eur J Pharmacol; 2016 Jan 05; 770():154-64. PubMed ID: 26593707
    [Abstract] [Full Text] [Related]

  • 19. A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway.
    Xie Y, Jin Y, Wen J, Li G, Huai X, Duan Y, Ni F, Fu J, Li M, Li L, Yan M, Cao L, Xiao W, Yang H, Wang ZZ.
    Biomed Pharmacother; 2024 Jul 05; 176():116908. PubMed ID: 38850668
    [Abstract] [Full Text] [Related]

  • 20. Effects of Danhong injection on dyslipidemia and cholesterol metabolism in high-fat diets fed rats.
    Du H, Li C, Wang Z, He Y, Wang Y, Zhou H, Wan H, Yang J.
    J Ethnopharmacol; 2021 Jun 28; 274():114058. PubMed ID: 33766756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.